| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.25 | 5e-08 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-07 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-06 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-05 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.18 | 0.0001 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |